Search Results

You searched for : Catalent

	BioShin enrolls first patient into an Asia-Pacific regional multi-center phase III clinical trial of rimegepant (BHV-3000) for the acute treatment of migraine BHV3000-310 is a double-blind, randomized trial evaluating the safety and efficacy of rimegepant in the acute treatment of migraine.... Nov 23
	Catalent acquires Bone Therapeutic's cell therapy manufacturing subsidiary SCTS Under the terms of the transaction, Catalent acquires Bone Therapeuticsâ€™ cell therapy manufacturing subsidiary, SCTS, for gross proceeds of â‚¬12 million... Nov 18
	Catalent launches OptiGel DR, a delayed/enteric release Softgel The drug delivery innovation major launches Softgel for Pharmaceutical and Nutraceutical Applications... Oct 24
	T-knife-Catalent sign Technology Transfer and Manufacturing Agreement for Cancer therapy Manufacturing agreement for Autologous T-Cell Receptor-Based Cell Therapy... Sep 24
	Catalent signs manufacturing agreement with AstraZeneca for COVID-19 Vaccine AZD1222 Catalent and Astrazeneca partners for the Covid vaccine manufacturing... Aug 26
	Moderna Vaccine Phase 1 trial shows it to be safe for patients Phase 1 trials establishes the safety level of Moderna's vaccine candidate... Jul 16
	Moderna and Catalent Announce Collaboration for Fill-Finish Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Modernaâ€™s COVID-19 Vaccine Candidate... Jun 26
	Catalent partners with ViralClear Pharmaceuticals ; COVID-19 treatment Catalent partners with ViralClear Pharmaceuticals on a potential treatment for COVID-19 ... Jun 25
8 Matching result(s) found!

-Advertisements-

Trending Now
	Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
	The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
	Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
	The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
	FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
	Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
	Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
	10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
	Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
	Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
	The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
	Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
	After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
	Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
	FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
	Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
	Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
	Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
	Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
	IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024

Search Results

BioShin enrolls first patient into an Asia-Pacific regional multi-center phase III clinical trial of rimegepant (BHV-3000) for the acute treatment of migraine

Catalent acquires Bone Therapeutic's cell therapy manufacturing subsidiary SCTS

Catalent launches OptiGel DR, a delayed/enteric release Softgel

T-knife-Catalent sign Technology Transfer and Manufacturing Agreement for Cancer therapy

Catalent signs manufacturing agreement with AstraZeneca for COVID-19 Vaccine AZD1222

Moderna Vaccine Phase 1 trial shows it to be safe for patients

Moderna and Catalent Announce Collaboration for Fill-Finish

Catalent partners with ViralClear Pharmaceuticals ; COVID-19 treatment

Trending Now